Related Experiment Video
Updated: Feb 11, 2026

Quantifying X-Ray Fluorescence Data Using MAPS
Published on: February 17, 2018
Microfocus x-ray fluorescence mapping of tumour penetration by an organo‑osmium anticancer complex
Carlos Sanchez-Cano1, Isolda Romero-Canelón2, Kalotina Geraki3
1Department of Chemistry, University of Warwick, Coventry CV4 7AL, UK.
Abstract:
Microfocus synchrotron x-ray fluorescence (SXRF) imaging focussed on detection of the Os LIII edge shows that the organo‑osmium metallodrug candidate [(ŋ6-p-cym)Os(Azpy-NMe2)I]+ (p-cym = p-cymene, Azpy-NMe2 = 2-(p-([dimethylamino]phenylazo)pyridine)) [1] penetrates efficiently into the interior of A2780 human ovarian cancer cell spheroids, a model for a solid tumour. The accompanying changes in Zn and Ca distribution suggest that the complex causes nuclear damage and initiates signalling events for cell death, consistent with findings for cultured cancer cell monolayers. Such tumour penetration is likely to be important for combatting resistance to chemotherapy, which is becoming a problem for current clinical platinum drugs.
Insights
A novel organo-osmium drug candidate effectively penetrates ovarian cancer cell spheroids, indicating potential for treating solid tumors. This metallodrug may overcome chemotherapy resistance, offering new hope against platinum-drug resistant cancers.
Area of Science:
- Medicinal Chemistry
- Cancer Research
- Materials Science
Background:
- Solid tumors present a challenge for chemotherapy due to poor drug penetration.
- Metallodrugs are an emerging class of therapeutic agents with unique mechanisms of action.
- Osmium-based compounds are being investigated for their anti-cancer properties.
Purpose of the Study:
- To investigate the tumor penetration of the organo-osmium metallodrug candidate [(ŋ⁶-p-cym)Os(Azpy-NMe₂)I]⁺.
- To assess the effects of the metallodrug on intracellular zinc and calcium distribution within cancer cells.
- To evaluate the potential of this metallodrug in overcoming chemotherapy resistance.
Main Methods:
- Microfocus synchrotron X-ray fluorescence (SXRF) imaging was employed to detect the Os L edge.
- A2780 human ovarian cancer cell spheroids were used as a model for solid tumors.
- Changes in Zn and Ca distribution were analyzed in response to drug treatment.
Main Results:
- The organo-osmium complex demonstrated efficient penetration into the interior of ovarian cancer cell spheroids.
- Significant alterations in Zn and Ca distribution were observed, suggesting nuclear damage.
- The drug initiated signaling events indicative of cell death, consistent with monolayer studies.
Conclusions:
- The tested organo-osmium metallodrug exhibits promising tumor penetration capabilities.
- The observed intracellular changes suggest a mechanism involving nuclear damage and cell death induction.
- This metallodrug holds potential for combating chemotherapy resistance in solid tumors, particularly against platinum-drug resistant cancers.
Related Concept Videos
X-ray Crystallography
Diffraction
Diffraction is the change in the direction of travel experienced by an electromagnetic wave when it encounters a physical barrier whose dimensions are comparable to those of the wavelength of the light. X-rays are electromagnetic radiation with wavelengths about as long as the distance between neighboring...
Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
X-ray Imaging
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Complex Numbers

